
11 - 50 employees
Founded 2015
🧬 Biotechnology
💊 Pharmaceuticals
💰 $1.9M Grant on 2022-01
Biotechnology • Pharmaceuticals
Shasqi is a clinical-stage biotech company developing a pre-targeting tumor therapy platform called CAPAC (Click Activated Protodrugs Against Cancer) that uses in‑vivo click chemistry to capture and activate therapeutic payloads at tumors. Their modular approach separates a tumor-binding clickable molecule from an inert clickable payload (radioisotope or chemotherapy protodrug) which becomes activated or locked at the tumor after a bioorthogonal click reaction, aiming to increase tumor drug concentration and reduce systemic toxicity. Shasqi reports clinical validation of the platform and is advancing pipeline assets and collaborations to bring pre‑targeted cancer therapies to patients.
🕒 July 27
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
Founded 2015
🧬 Biotechnology
💊 Pharmaceuticals
💰 $1.9M Grant on 2022-01
Biotechnology • Pharmaceuticals
Shasqi is a clinical-stage biotech company developing a pre-targeting tumor therapy platform called CAPAC (Click Activated Protodrugs Against Cancer) that uses in‑vivo click chemistry to capture and activate therapeutic payloads at tumors. Their modular approach separates a tumor-binding clickable molecule from an inert clickable payload (radioisotope or chemotherapy protodrug) which becomes activated or locked at the tumor after a bioorthogonal click reaction, aiming to increase tumor drug concentration and reduce systemic toxicity. Shasqi reports clinical validation of the platform and is advancing pipeline assets and collaborations to bring pre‑targeted cancer therapies to patients.
• Accountable for the translational development strategy for pipeline assets from drug candidate through IND submission and Phase 1 entry. • Support translational hypotheses and biomarker strategies that connect preclinical biology to clinical endpoints. • Support indication selection frameworks and biomarker-driven go/no-go criteria that guide program progression decisions. • Support targeted patient stratification and enrichment strategies that inform clinical trial design and improve probability of success. • Identify and prioritize experiments, models, and data packages needed to support regulatory filings and clinical decision-making. • Partner with research and clinical leadership to align translational milestones with overall program strategy. • Characterize drug mechanisms of action and resistance to inform clinical hypotheses, patient selection, and combination strategies. • Lead the scientific content and coordination of IND-enabling activities, including PK/PD, safety, and biomarker packages. • Author and review translational sections of INDs, investigator brochures, and other regulatory documents. • Serve as the translational science lead in interactions with FDA and other regulatory agencies. • Ensure preclinical-to-clinical bridging is scientifically rigorous and clearly communicated. • Collaborate closely with Research (animal models, PK/PD, efficacy), Clinical Development, Clinical Operations, and CMC to ensure translational readiness at each program gate. • Support clinical protocol development by providing translational rationale for dosing, scheduling, patient selection, and biomarker collection. • Contribute to the design and interpretation of early clinical data to inform go/no-go decisions and Phase 2 design. • Build, mentor, and scale the translational science function as programs grow. • Identify and manage together with research and clinical leadership, academic collaborators, CROs, and biomarker labs that support translational programs. • Represent Shasqi's translational science at conferences, in publications, and in partnership discussions. • Co-author scientific publications, regulatory documents, and contribute to IP filings that protect and advance Shasqi’s platform. • Articulate Shasqi’s translational strategy and platform differentiation to the board and other external partners/investors as needed.
• Ph.D., M.D., or M.D./Ph.D. in oncology, pharmacology, cancer biology, or a related field. • 12+ years experience in translational oncology drug development at a biotech or pharma company, including personally leading and advancing at least two programs from preclinical candidates through IND filing and into Phase 1. • Deep understanding of IND-enabling studies and the preclinical data packages required by the FDA and other regulatory agencies. • Hands-on experience with PK/PD, biomarker strategy, and dose selection for oncology programs. • Strong scientific writing skills with experience authoring regulatory documents. • Ability to work at the bench-to-bedside interface in a small, fast-moving team. • Comfort being the most senior translational scientist in the company — supporting the design of studies and authoring regulatory documents directly, with limited support infrastructure and a high tolerance for ambiguity.
• Competitive base salary as part of a broader total rewards package. • Equity: Included as part of total compensation. • Comprehensive benefits: medical, dental, vision, 401(k), short- and long-term disability. • Flexible PTO and a WFH stipend to support remote work. • Ongoing opportunities for professional development, growth, and mentorship.
Apply Now🕒 July 27
VP Manufacturing providing strategic, operational, and technical leadership for biologics manufacturing activities. Establishing scalable, compliant manufacturing capabilities and ensuring regulatory compliance.
🕒 July 27
🕒 July 27
Vice President of Technical Services leading repair operations and support for customer satisfaction. Maximizing equipment availability through operational excellence and continuous improvements in processes.
🕒 July 27
SVP of Sales driving BPO sales for a global customer experience consulting firm. Leading sales cycles and managing enterprise pursuits with a focus on solution development.
🕒 July 27
Vice President of Operations overseeing operations of behavioral health facilities within Advanced Recovery Systems. Ensuring compliance, performance, and operational excellence across the organization.